Install
Cancellations, Closures & Delays Meet Our Marketing Gurus Green Gold Fan Zone Never Forgotten Honor Flight Grand Theater 2025-26 Season ↪ How to Listen: Apps & Smart Speakers!
- 3,558articles · 30d
- 2+ hour agolatest article
- Aug 15, 2026earliest in window
- 15%with images
- 269avg words
- business 1,251
- world 1,032
- world news 950
- politics 803
- sports 793
- (midwest communications 599
- donald trump 560
- markets 513
- mc complete - state & national 508
- conservative talk 507
- brian kilmeade 470
- clay travis 433
- buck sexton 400
- sean hannity 376
- technology 367
- economy 358
- mark levin 350
- finance 325
- joe pags 319
- europe 288
- News 1,184
- Economy, Business & Finance 1,121
- Politics 905
- Finance & Business 877
- Sports & Fitness 774
- Sports 771
- Sport 705
- Sensitive Subjects 568
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Astrazeneca’s breast cancer drug fails late-stage trial
2+ day, 13+ hour ago (77+ words) Sept 11 (Reuters) - AstraZeneca said on Friday its breast cancer drug failed to meet the main goal of improving progression-free survival during a late-stage trial. (Reporting by Christy Santhosh in Bengaluru; Editing by Tasim Zah... Astrazeneca’s breast cancer drug fails late-stage…...
US FDA pauses new enrollment in Biohaven’s epilepsy drug trials
3+ day, 22+ hour ago (278+ words) Sept 10 (Reuters) – Biohaven said on Thursday the U.S. FDA had imposed a partial clinical hold, pausing new patient enrollment in trials of its experimental epilepsy drug after rodent findings, sending its shares down more than 13% in premarket trading. Here are…...
Evommune scraps eczema drug after trial miss, shares plunge
5+ day, 12+ hour ago (199+ words) Sept 8 (Reuters) – Evommune said on Tuesday it will not advance its experimental skin disease drug after it failed to meet the main goal in a mid-stage trial, sending its shares down 24% in aftermarket trading. Here are some details • The company…...
Roivant’s experimental lung disease drug meets goals in mid-stage study
5+ day, 23+ hour ago (262+ words) Sept 8 (Reuters) – Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients with high blood pressure associated with a type of lung disease, sending shares up about 20% in premarket trading. Roivant has been…...
Transgene jumps 20% on positive cancer vaccine data in early trial
1+ week, 4+ day ago (191+ words) Sept 3 (Reuters) – Transgene shares surged 20% in early Paris trading on Thursday, after the French biotechnology company reported positive Phase 1 trial data on its vaccine candidate for head and neck cancer. Investors have rewarded encouraging data from other personalised cancer-vaccine programmes…...
Ultragenyx’s rare disease drug fails in late-stage trial; shares plunge
1+ week, 4+ day ago (135+ words) Sept 2 (Reuters) – Ultragenyx Pharmaceutical said on Wednesday its experimental drug for a rare genetic neurodevelopmental disorder did not meet the main goal in a late-stage trial, sending its shares down 40% in aftermarket trading. The drug, apazunersen, was tested as a…...
Roche signs global licensing pact for Simcere’s experimental blood cancer drug
1+ week, 5+ day ago (117+ words) Sept 1 (Reuters) – Switzerland’s Roche will pay $75 million upfront to Simcere Pharmaceutical Group for rights to an experimental blood cancer drug, the Chinese drugmaker said Tuesday. • SIM0660 targets B-cell malignancies, Simcere said in a filing to the Hong Kong stock exchange. • B…...
UK regulator suspends Amgen’s Tavneos for new patients over unreliable data
1+ week, 5+ day ago (270+ words) Sept 1 (Reuters) – Britain’s medicines regulator on Tuesday suspended the use and sale of Amgen’s rare-disease drug, Tavneos, to new patients, saying the main study supporting its approval was unreliable. • The drug, sold as Avacopan Vifor in Britain by CSL Vifor,…...
Exclusive-US refusals of crucial newborn vitamin spike, raising risk of dangerous bleeding
1+ week, 6+ day ago (1084+ words) CHICAGO, Sept 1 (Reuters) – The percentage of parents and caregivers in the United States refusing a standard vitamin K shot for infants at birth has accelerated sharply this year, an exclusive data analysis for Reuters found, putting more newborns at risk…...
AstraZeneca lung cancer therapy combination shows promise in advanced study
1+ week, 6+ day ago (94+ words) Sept 1 (Reuters) - AstraZeneca said on Tuesday that a Chinese late-stage trial of a combination of its cancer drugs Tagrisso and Orpathys significantly improved progression-free survival when given as a first-line treatment for a type of... AstraZeneca lung cancer therapy combination…...